Literature DB >> 911655

Further aspects of nomifensine pharmacology.

B Costall, R J Naylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 911655      PMCID： PMC1429118          DOI： 10.1111/j.1365-2125.1977.tb05764.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Serotoninergic modulation of the dopamine response from the nucleus accumbens.

Authors:  B Costall; R J Naylor; C D Marsden; C J Pycock
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

2.  Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.

Authors:  H J Gerhards; A Carenzi; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

4.  The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 6.  Parkinson's disease: from brain homogenate to treatment.

Authors:  O Hornykiewicz
Journal:  Fed Proc       Date:  1973-02

7.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.

Authors:  P Hunt; M Kannengiesser; J Raynaud
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

8.  Design of agents for stimulation of neostriatal dopaminergic mechanisms.

Authors:  B Costall; R J Naylor; R M Pinder
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765

9.  Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens.

Authors:  A J Pijnenburg; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

10.  The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.

Authors:  B Costall; C D Marsden; R J Naylor; C J Pycock
Journal:  Brain Res       Date:  1976-12-10       Impact factor: 3.252
View more
  3 in total

Review 1.  Formation of active metabolites of psychotropic drugs. An updated review of their significance.

Authors:  S Caccia; S Garattini
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Rapid eye movement sleep and sleep continuity. Depression and antidepressants.

Authors:  A N Nicholson; P A Pascoe
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.